Print

Novartis AG Withdraws Joicela Marketing Application in Europe  
4/19/2011 7:06:55 AM

Bloomberg -- Novartis AG (NOVN) withdrew its application to market the Joicela pain pill in the European Union because the Swiss company wasn’t able to provide information to regulators in the time allowed.
//-->